Why isn't a woman being burnt alive on an English street a huge news story?
New ABC Social Media rules designed to stop Louise Milligan making more of an idiot of herself.

Another paper on Ivermectin-Based Multidrug Therapy in Severe Hypoxic Ambulatory COVID-19 Patients

This paper on the effectiveness of Ivermectin comes from Sydney, Australia's Dr Thomas Borody and colleagues.

Screen Shot 2021-08-09 at 8.59.42 am

Ivermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ RCTs. Having developed combination therapies for Helicobacter pylori , we tested various COVID-19 combinations and describe the most effective. In 24 consecutive COVID-19 subjects with high risk features, hypoxia and untreated moderate-severe symptoms averaging 9 days, we trialed this novel combination comprising ivermectin, doxycycline, zinc, and Vitamins D and C. It was highly effective. All subjects resolved symptoms in 11 days on average, and oxygen saturation improved in 24hrs (87.4% to 93.1%, p =0.001). Hospitalizations and deaths were significantly fewer ( p <0.002 or 0.05, respectively) than in background-matched controls from the CDC database. Triple combination therapy is safe and effective even in moderate-severe patients with hypoxia treated in the outpatient setting. Trial Registration N/A, see methods.